Snail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas

Neuropathology

Volumn 30, Issue 3, 2010, Pages 224-231

  Myung, Jaekyung ^a   Cho, Byung Kyu ^b,c   Kim, Young Soon ^a   Park, Sung Hye ^a,c  

^a Samsung Medical Center   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Cox 2; Glioma; Immunohistochemistry; Prognostic factor; Snail

Indexed keywords

CYCLOOXYGENASE 2; TRANSCRIPTION FACTOR SNAIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; SCHOOL CHILD; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; INFANT; MALE; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TRANSCRIPTION FACTORS; WORLD HEALTH ORGANIZATION;

EID: 77952921851     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2009.01072.x     Document Type: Article

References (59)

1. Wong ML, Kaye AH, Hovens CM. Targeting malignant glioma survival signalling to improve clinical outcomes. J Clin Neurosci 2007 14 : 301 308.
2. Morokoff AP, Novak U. Targeted therapy for malignant gliomas. J Clin Neurosci 2004 11 : 807 818.
3. D'Abaco GM, Kaye AH. Integrins: molecular determinants of glioma invasion. J Clin Neurosci 2007 14 : 1041 1048.
4. Wick W, Naumann U, Weller M. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 2006 12 : 341 349.
5. Koul D, Shen R, Bergh S et al. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Mol Cancer Ther 2005 4 : 1681 1688.
6. Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 2005 7 : 134 153.
7. Knott JC, Mahesparan R, Garcia-Cabrera I et al. Stimulation of extracellular matrix components in the normal brain by invading glioma cells. Int J Cancer 1998 75 : 864 872.
8. Phillips HS, Kharbanda S, Chen R et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006 9 : 157 173.
9. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999 24 : 73 76.
10. Behrens J, Frixen U, Schipper J, Weidner M, Birchmeier W. Cell adhesion in invasion and metastasis. Semin Cell Biol 1992 3 : 169 178.
11. Grooteclaes ML, Frisch SM. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000 19 : 3823 3828.
12. Batlle E, Sancho E, Franci C et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000 2 : 84 89.
13. Cano A, Perez-Moreno MA, Rodrigo I et al. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000 2 : 76 83.
14. Comijn J, Berx G, Vermassen P et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001 7 : 1267 1278.
15. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002 34 : 255 268.
16. Nieto MA. The Snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002 3 : 155 166.
17. Jorda M, Olmeda D, Vinyals A et al. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci 2005 118 : 3371 3385.
18. Guaita S, Puig I, Franci C et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002 277 : 39209 39216.
19. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004 48 : 365 375.
20. Blanco MJ, Moreno-Bueno G, Sarrio D et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002 21 : 3241 3246.
21. Sugimachi K, Tanaka S, Kameyama T et al. Transcriptional repressor Snail and progression of human hepatocellular carcinoma. Clin Cancer Res 2003 9 : 2657 2664. (Pubitemid 36842110)
22. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, Nieto MA. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004 18 : 1131 1143.
23. Kajita M, McClinic KN, Wade PA. Aberrant expression of the transcription factors Snail and slug alters the response to genotoxic stress. Mol Cell Biol 2004 24 : 7559 7566.
24. Dohadwala M, Yang SC, Luo J et al. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and Snail in non-small cell lung cancer. Cancer Res 2006 66 : 5338 5345.
25. Dannenberg AJ, Zakim D. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin Oncol 1999 26 : 499 504.
26. Dannenberg AJ, Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 2003 4 : 431 436.
27. Huang M, Stolina M, Sharma S et al. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 1998 58 : 1208 1216.
28. Onguru O, Gamsizkan M, Ulutin C, Gunhan O. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma. Neuropathology 2008 28 : 29 34.
29. Joki T, Heese O, Nikas DC et al. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 2000 60 : 4926 4931.
30. Lin CC, Kenyon L, Hyslop T et al. Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol 2003 26 : S98 102.
31. Onguru O, Kurt B, Gunhan O, Soylemezoglu F. Cyclooxygenase-2 (cox-2) expression and angiogenesis in intracranial ependymomas. Clin Neuropathol 2006 25 : 216 220.
32. Onguru O, Scheithauer BW, Kovacs K et al. Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas. Endocr Pathol 2004 15 : 17 27.
33. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 2001 61 : 4375 4381.
34. Hara A, Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 2004 108 : 43 48.
35. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002 2 : 442 454.
36. Arias AM. Epithelial mesenchymal interactions in cancer and development. Cell 2001 105 : 425 431.
37. Hemavathy K, Ashraf SI, Ip YT. Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 2000 257 : 1 12.
38. Seki K, Fujimori T, Savagner P et al. Mouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecan. J Biol Chem 2003 278 : 41862 41870.
39. Ding JX, Feng YJ, Yao LQ, Yu M, Jin HY, Yin LH. The reinforcement of invasion in epithelial ovarian cancer cells by 17 beta-Estradiol is associated with up-regulation of Snail. Gynecol Oncol 2006 103 : 623 630.
40. Yin T, Wang C, Liu T, Zhao G, Zha Y, Yang M. Expression of Snail in pancreatic cancer promotes metastasis and chemoresistance. J Surg Res 2007 141 : 196 203.
41. Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors Snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005 12 : 488 496.
42. Elias MC, Tozer KR, Silber JR et al. TWIST is expressed in human gliomas and promotes invasion. Neoplasia 2005 7 : 824 837.
43. Yang J, Mani SA, Donaher JL et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004 117 : 927 939.
44. Kwok WK, Ling MT, Lee TW et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005 65 : 5153 5162.
45. Entz-Werle N, Stoetzel C, Berard-Marec P et al. Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas. Int J Cancer 2005 117 : 349 355.
46. Kyo S, Sakaguchi J, Ohno S et al. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006 37 : 431 438.
47. Lippman SM, Gibson N, Subbaramaiah K, Dannenberg AJ. Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways. Clin Cancer Res 2005 11 : 6097 6099. (Pubitemid 41262933)
48. Esteller M, Garcia-Foncillas J, Andion E et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000 343 : 1350 1354.
49. Silber JR, Bobola MS, Ghatan S, Blank A, Kolstoe DD, Berger MS. O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. Cancer Res 1998 58 : 1068 1073.
50. Martinez R, Schackert G, Yaya-Tur R, Rojas-Marcos I, Herman JG, Esteller M. Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme. J Neurooncol 2007 83 : 91 93.
51. Jaeckle KA, Eyre HJ, Townsend JJ et al. Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J Clin Oncol 1998 16 : 3310 3315.
52. Weingart J, Grossman SA, Carson KA et al. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. J Clin Oncol 2007 25 : 399 404.
53. Quinn JA, Desjardins A, Weingart J et al. Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol 2005 23 : 7178 7187.
54. Kesari S, Ramakrishna N, Sauvageot C, Stiles CD, Wen PY. Targeted molecular therapy of malignant gliomas. Curr Neurol Neurosci Rep 2005 5 : 186 197.
55. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002 2 : 616 626.
56. Agosti RM, Leuthold M, Gullick WJ, Yasargil MG, Wiestler OD. Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme. Virchows Arch A Pathol Anat Histopathol 1992 420 : 321 325.
57. Bigner SH, Humphrey PA, Wong AJ et al. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 1990 50 : 8017 8022.
58. Fraga MF, Esteller M. DNA methylation: a profile of methods and applications. Biotechniques 2002 33 : 632, 634, 636 649.
59. Layfield LJ, Willmore C, Tripp S, Jones C, Jensen RL. Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl Immunohistochem Mol Morphol 2006 14 : 91 96.